A phase II single-arm trial of memantine for prevention of cognitive decline during chemotherapy in patients with early breast cancer: Feasibility, tolerability, acceptability, and preliminary effects
February 8, 2023
This is one of the first studies to examine the use of a medication to minimize cognitive changes that may occur during chemotherapy for breast cancer.